Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on June 8, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

65--NOI - Oxford Nanopore PromethION Flow Cells and cD

Closed
75N98026Q00477Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The contract involves a non-competitive, firm-fixed-price purchase order issued by the National Institutes of Health (NIH) under solicitation number 75N98026Q00477. It is a combined synopsis/solicitation set forth in accordance with FAR Subpart 12.6 and conducted under streamlined acquisition authorities, not expected to exceed the simplified acquisition threshold. The NIH Office of the Director, Office of Acquisitions, intends to award the contract directly to Oxford Nanopore Technologies Inc. for the procurement of PromethION flow cells and cDNA-PCR sequencing kits. These proprietary items are essential for supporting the National Institute on Aging's Center for Alzheimer's Disease and Related Dementias (CARD) long-read RNA sequencing project on ROSMAP brain samples, enabling compatibility with CARD's existing PromethION 48 sequencing infrastructure and facilitating direct comparison with prior long-read whole-genome sequencing data. Oxford Nanopore Technologies Inc. is the sole manufacturer of the specified products, including the FLO-PRO114M flow cells and the SQK-LSK114-XL cDNA-PCR Sequencing Kit V14, justifying the non-competitive nature of the acquisition. The solicitation was posted on May 29, 2026, with a response deadline of June 8, 2026. The contract falls under NAICS code 325413 and is administered through the NIH Office located in Bethesda, Maryland. All communications or inquiries regarding the solicitation may be directed to the identified point of contact, Nicholas S. Capobianco. This procurement supports critical scientific research and aligns with federal acquisition regulations that allow for streamlined processing when dealing with sole-source commercial items.

General Info

NIH awards sole-source fixed-price contract to Oxford Nanopore for proprietary sequencing kits.

Agency

Department Of Health And Human Services → National Institutes Of Health Olao

Contract Value

$252,560

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing View NAICS

Place of Performance

MD

Set-Aside

NONE

Awardee

OXFORD NANOPORE TECHNOLOGIES INCView Profile

Award Issued Date

Documents

(3)

RFQ 75N98026Q00477 for Oxford Nanopore Sequencing Kits

PDFrfq

Amendment 0001 to RFQ 75N98026Q00477 for Oxford Nanopore Sequencing Supplies

PDFamendment

75N98026Q00477_Amendment1_0001.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

1 update
PhaseClosed
Posted

Combined Synopsis

Amendment 1

Contract was updated

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao
Contacts1 person available
OfficeBETHESDA, MD, 20892, USA
Organization / Agency
Department Of Health And Human Services → National Institutes Of Health Olao
Office AddressBETHESDA, MD, 20892, USA
Contacts

Full Description

Show more
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued.
(ii) The solicitation number is 75N98026Q00477. This solicitation is issued as a Notice of Intent (NOI) for a non-competitive combined synopsis/solicitation to award a contract or purchase order without providing for full and open competition (brand-name).
This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii).
The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a Firm-Fixed-Price purchase order on a non-competitive basis to Oxford Nanopore Technologies Inc., One Kendall Square, Building 1400, Suite 14-305, Cambridge, MA 02139 for PromethION flow cells and cDNA-PCR sequencing kits required to support the National Institute on Aging's Center for Alzheimer's Disease and Related Dementias (CARD) long-read RNA sequencing project on ROSMAP brain samples. Oxford Nanopore Technologies Inc. is the sole manufacturer of the proprietary flow cells (FLO-PRO114M) and cDNA-PCR Sequencing Kit V14 (SQK-LSK114-XL) required to operate CARD's existing PromethION 48 sequencing infrastructure and to enable direct matched comparison with previously generated long-read whole-genome sequencing data on the same ROSMAP samples.